Palvella THERAPEUTICS, Inc. (PVLA) intrinsic value & 10-year financials
Palvella THERAPEUTICS, Inc. (PVLA) has a Graham intrinsic value of $14.42 per share. At $120.30 on Oct 17, 2026, the stock trades 734% above that value.
- Graham intrinsic value
- $14.42
- Share price (Oct 17, 2026)
- $120.30
- Price vs Graham value
- 734% above
- Market cap
- $1.4B
- Revenue (FY2025)
- —
- Revenue growth (10-yr CAGR)
- 31.1%
- ROIC (10-yr avg)
- 97.2%
- Free cash flow (FY2025)
- —
PVLA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$41.7M | -$3.71 | — | — | 152.7% |
| FY2024 | — | -$17.4M | -$1.57 | — | — | 242.3% |
| FY2023 | $38.7M | -$24.5M | $0.43 | -$54.0M | -76.9% | -546.0% |
| FY2022 | $25.5M | -$33.3M | — | -$61.0M | -170.7% | 168.4% |
| FY2021 | $27.9M | -$45.7M | -$0.14 | -$8.6M | -185.5% | 135.2% |
| FY2020 | $23.9M | -$37.2M | -$0.14 | -$48.6M | -141.9% | 358.9% |
| FY2019 | $43.6M | -$25.5M | — | -$54.9M | -62.2% | 178.9% |
| FY2018 | $27.2M | -$26.8M | — | -$2.8M | -113.1% | 87.2% |
| FY2017 | $25.3M | -$17.6M | — | $47.8M | -57.7% | — |
| FY2016 | $5.8M | -$22.8M | — | -$15.0M | -390.3% | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
PALVELLA THERAPEUTICS, INC. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
PALVELLA THERAPEUTICS, INC. has earned high returns on invested capital, averaging 28.5% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
PALVELLA THERAPEUTICS, INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, PALVELLA THERAPEUTICS, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $14.42 per share.